Heart Disease Trial, Recruiting NCT04343443 Sponsor: Central Hospital, Nancy, France Condition: Heart Disease
Back to Heart Disease

Heart Disease Trial, Recruiting

NCT04343443
Recruiting Not Applicable

Who may be able to join

AI generated eligibility summary. Written by an AI model from the official source data and checked on a sample basis. It can contain mistakes, so confirm anything important against the original source. How we use AI

Who might be able to join this trial:

  • People who are currently in hospital being treated for sudden (acute) worsening heart failure
  • People whose heart is not pumping as strongly as it should be (the heart's pumping strength is measured as less than 50%)
  • People who are considered medically ready to be discharged from hospital after their acute heart failure treatment
  • People aged 18 years or older
  • People who have been fully informed about the study and have signed a consent form agreeing to take part
  • People who are covered by or benefit from a social security scheme

Who may not be able to join:

  • People who have another serious illness where life expectancy is 3 months or less
  • People on kidney dialysis (any type), or whose kidneys are functioning at a very low level at the time of joining the study
  • People who have previously had surgery to remove part or all of a lung
  • People with serious lung or chest lining conditions that would make lung ultrasound scans unreliable, such as severe emphysema, long-term fluid around the lungs, or lung scarring (confirm with trial site)
  • People who are pregnant, in labour, or currently breastfeeding
  • People who are legally unable to give consent, or who are under a legal protection arrangement such as guardianship or curatorship
  • People who are currently held in custody or detained under a judicial or administrative decision
  • People currently receiving compulsory psychiatric care under specific French public health laws (confirm with trial site)

Important: Always verify eligibility with the trial site directly before applying.

Based on publicly available eligibility criteria from ClinicalTrials.gov. Verify directly with the trial site before acting. This is not medical advice.

This is a simplified plain English summary of the eligibility criteria. Full criteria are set by the trial investigators and may include additional requirements not shown here. Never self-exclude from a trial based on this summary. Contact the trial site directly to confirm your eligibility.
Last synced 12 July 2026
This study is not part of the standard drug-approval phase pathway (for example an observational, device, behavioural, or registry study), so a phase success rate does not apply.

Contact this trial

Phone: + 33 3 83 15 73 22

Contact details sourced from ClinicalTrials.gov. Verify directly with the trial site before attending.

GP referral letter

Print a one-page summary to share with your doctor.

Trial details

Status
Recruiting
Phase
Not Applicable
Registry
ClinicalTrials.gov
Start date
21 August 2020
Est. completion
21 August 2026

Where this trial is recruiting

🇫🇷 France

Primary endpoints

Rate of all-cause death; Rate of re-hospitalisation for acute heart failure; Rate of day-hospital or in-home IV diuretics injection for acute HF

Can't join this trial?

Expanded access pathways

If this trial is not available to you, other access pathways may exist. In Australia, the TGA Special Access Scheme allows access to unapproved therapeutic goods for individual patients.

TGA Special Access Scheme information

Find other recruiting trials on ClinicalTrials.gov

Data last synced from ClinicalTrials.gov: 12 July 2026. Trial status can change. Always verify current status directly with the trial site before making any decision.

Trial recruitment status can change without notice between our nightly data updates. Always contact the trial site directly to confirm current recruitment status before making any decisions or travel arrangements.

View original record on ClinicalTrials.gov